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Inflammatory bowel disease (IBD) is a set of disorders that involve chronic
inflammation of digestive tracts, e.g., Crohn's disease (CD) and ulcerative colitis (UC).
Millions of people around the world have inflammatory bowel disease. However, it is
still difficult to treat IBD due to its unknown cause. In fact, accurately diagnosing
inflammatory bowel disease (IBD) can be very challenging too since some of IBD
symptoms can mimic those of other conditions. In this work, we apply classification
methods to help improve the success rate of diagnosis. We study four formulations of
IBD classification: i) IBD and non-IBD (binary classification), ii) CD and non-IBD
(binary classification), iii) UC and non-IBD (binary classification), and iv) UC, and
non-IBD (ternary classification). We have applied a number of classification methods,
including decision tree, Naive Bayes, K-nearest neighbor, and rule-based classifier, to the
two IBD classification problems using a metagenomic dataset collected from stool
samples. Our study shows that a rule-based classifier achieves the best combination of
classification accuracy and readability. We also explored the roles of attributes in the
diagnosis of IBD based on interpretation of learned models. Studying the importance of
specific attributes could lead to a better understanding of IBD by either discovering new
connections or reinforcing known ones.
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Chapter 1. Introduction
Inflammatory bowel disease (IBD) is a group of disorders that cause chronic
inflammation of the gastrointestinal (GI) tract that causes an array of symptoms. Over 3.5
million people are diagnosed with IBD and that number is still increasing, not only in
North America and Europe where is it most common, but also around the world [1].
There are two main types of IBD with the majority of diagnoses: Crohn’s disease (CD)
and ulcerative colitis (UC). While CD and UC are very similar, they do have specific
difference. CD can affect anywhere along whole GI tract (from mouth to anus) with
damaging inflammation appearing in patches and with the possibility of reaching
multiple layers of the GI tract wall, while UC can only affect the large intestine (colon)
and sometimes rectum, with damage continuous and inflammation is only in the
innermost layer of the colon lining [2].
CD and UC are very similar with their symptoms and most (but not all) treatment
options. However, if surgery is required, the type of surgery and area operated on are
different due to the difference in inflammation. Due to the continuous damage of UC, it is
far easier to perform a removal surgery to remove only the parts of the colon that are
affected. CD’s damage often cannot be simply removed because it only appears in
scattered patches and/or it may appear in areas that cannot be removed. [3]. For this
reason, the distinction between CD and UC in IBD diagnosis is important so that medical
professionals and patients are aware of all options open to them.
While IBD is not fatal (unless there are major complications), it has a large
impact on the lives of those who have the disease, especially if remission cannot be
reached. Common symptoms include but not limited to abdominal cramps and pain,
1

fatigue, diarrhea, and bloody stools. IBD also increases chances of having many other
diseases or disorders such as, cardiovascular disease, respiratory disease, cancer, arthritis,
weak or failing kidneys, any liver condition, and ulcer [4]. IBD can bring additional
challenges from the symptoms and risk factors. With the lack of public understanding of
IBD, patients can be treated with insensitivity to their condition, either by not
understanding the severity of their condition or not believing their condition at all. This
can cause them to keep their condition to themselves and fail to reach out for support
which in turn leads to stress, anxiety, depression, and/or other mental health problems.
The stress and cost of treatment and eve bathroom access can also provide more
challenges to patients [5].
The previously mentioned symptoms and possible other condition that IBD
patients can have may lead to a misunderstanding that a patient has other disorders such
as Irritable Bowel Syndrome, celiac disease, tuberculous enteritis, duodenal ulcer,
appendicitis, anal fistula, enterocolitis, hemorrhoids, rectal varix, and rheumatoid arthritis
[2] [5]. In summary, IBD can be difficult to diagnose because its cause is unknown, and it
can be easily diagnosed as other diseases with similar appearing conditions. This can
cause many patients to go untreated while for medical professionals determine what
might be causing their symptoms and provide a correct diagnosis. A study performed by
Yong Hoon Kwon and Yong Joo Kim show that the average diagnostic time lag in
children with CD was 3.36 months, and with UC was 2.2 months but this time can
increase by month or years with an incorrect diagnosis [5]. This can cause patients to
suffer with symptoms longer than necessarily and receive treatment for a condition that
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they do not have which may harm them more. There are a few tests that medical
professionals order which all have varying goals, success, and burden on the patients
Although the exact cause of IBD is unknown, there are some known factors that
increase the chance of someone having it and changes in gut microbiota are seen as well.
These factors include, age, race/ethnicity, family history, smoking, and environment [6]
[7]. The change in the gut microbiota is highly debated because it is unknown whether
the change is the cause of the IBD or the consequence of it [8]. This debate between
change and consequence of the gut microbiota change causes many different paths in
treatments such as chemotherapy, complementary and alternative medicine, traditional
Chinese herbal medicine, prebiotics, probiotics, synbiotics, and fecal microbiota
transplantation. Some of these tests include, general blood test, stool test, medical
imaging, colonoscopy, and colon biopsy [9]. Despite the variety of test, the colonoscopy
is considered to the benchmark for monitor any IBD activity because of its accuracy and
the amount of the information that gained in comparison to the other tests. The
colonoscopy has an 89% accuracy of diagnosis of CD or UC [10]. With the proper
medication, many patients find remission and experience little to no symptoms.
With the complexity of medical diagnosis and the human body, it can be quite
difficult for humans to find the connects between the conditions of the human body and
varies disorders. All the different conditions in the human body from DNA to heart rate
to abundance of bacteria in a patient stool can be measured and recorded to produce large
dataset that focus on the wellbeing of the body. With the use of machine learning
techniques, these datasets can be processed to reveal knowledge the body that were not
previously known and possibly quite hard for humans to detect on their own. While
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machine learning technique cannot replace the knowledge, intuition, and experience of
medical professionals, they can be used as another tool to extend our understanding of the
problem. Just like any other tool, there is no tool that works for all problems. This is why
various machine learning techniques should be tested to find which one is best suited for
a specific problem or set of problems.
This thesis discusses the diagnosis of IBD using classification methods while
looking at three binary classifications (IBD and nonIBD, CD and nonIBD, UC and
nonIBD) and ternary classification (CD, UC, and nonIBD). The models used include
C4.5 Decision Tree, Naïve Bayes, k-Nearest Neighbor, RIPPER, and Decision Table.
The ensemble methods of bagging and boosting are also used on the C4.5 decision tree
and the RIPPER algorithm. The use of these classification models to diagnose IBD using
a Metagenomic dataset collected from stool samples. Waikato Environment for
Knowledge Analysis (WEKA) is used in the implementation of the classification models.
The findings of this thesis show that the RIPPER algorithm has great potential for
diagnosing IBD because of its interpretability, a higher classification accuracy than a
colonoscopy, and the rule set lines up with some known links between IBD and certain
bacteria.

4

Chapter 2. Literature Review
The use of data mining models and machine learning techniques in the medical
field is not a new area of research and there is research that looks directly at diagnosing
IBD. This allows for the comparisons of results, classification models, and datasets and
also a comparison to the current test standards. While the combination of the
classification models and metagenomic data is what being studied in the theis, the study
of metagenomic data from stool samples has been used to learn more about a patient’s
microbiota and test for infection.

2.1 Current IBD Testing Methods
Isabelle Noiseux et al. discusses the various test methods being used today and
studied the cost, refusal rates, comfort and fear levels, knowledge, etc. that patient
associate with the different tests in their study, “Inflammatory bowel disease patient
perceptions of diagnostic and monitoring tests and procedures” [9]. They collected survey
data through the Crohn’s and Colitis Canada association about the five common tests
used to test for IBD: general blood test, stool test, colonoscopy, colon biopsy and medical
imaging. The survey received 210 responds where 145 had CD and the other 65 had UC.
The study first looked at what tests were requested the most and were refused the most
with both being the general blood test even when it provides the least information. They
continued by investigating why patients refuse specific tests. The study continues by
looking at patients’ comfort, understanding of the tests, and what information about the
test was provided by the medical professional. This information can be used to help
decide what tests to order, where medical professional can improve when interacting with
5

patients, and understand how patients view the tests. Patients appeared to be most
comfortable with the stool sample and medical professionals need to provide more
information about risks of having false positive or negative tests.

2.2 Data Mining and Medicine
Elahe Parva et al. discusses the emerges of data mining in the medical field,
especially in emergency medicine in their paper, “The Necessity of Data Mining in
Clinical Emergency Medicine; A Narrative Review of the Current Literature” [11]. Parva
discusses the complexity of the body with its many systems and subsystems is much like
the complexity and connectivity of economic and military problems that already use
machine learning and statistics to effectively solve complex problems. Data mining
would not only help with understanding the body and diagnosis problems but also reduce
the waste of medical resources. Parva identifies the following areas of medical science as
potential places data mining analysis can be applied [11]:
x

Identifying the complex mechanisms of different body subsystems and
their interactions with each other

x

Identifying people who are at risk for diseases of a genetic predisposition
or caused by environmental factors

x

Identifying disease mechanisms and their interactions with the problems
of the body

x

Determining disease prognoses, and facilities management

x

Establishing decision support systems to make the best decision,
especially when the disease is multi-factorial, when more factors are
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involved in determining the course of the disease, in emergencies, or in
acute phases of a disease
x

Evaluating diagnostic and treatment tasks and relationships and
identifying shortcomings and capabilities

x

Finding the best screening methods for diseases and injuries, particularly
for patients in critical conditions.

The paper continues by discussing the studies that have already applied data
mining in various medical areas including, cancer, prognosis of patients after lung
transplantation, determining diseases and facilities management, and decision support
system.

2.3 Endoscopy and Histology
E. Mossotto et al. studies the use of ensemble learners, linear discriminant
analysis and support vector machine (SVM) for IBD diagnosis in their paper
“Classification of Paediatric Inflammatory Bowel Disease using Machine Learning” [12].
Mossotto’s research uses data obtained from endoscopy and histology (study of the
microscopic structure of tissues) at initial diagnosis from 287 IBD patients (178 CD, 80
UC, and 29 unclassified IBD (IBDU)). This study has no healthy controls to provide a
baseline for people with IBD, which means that this study only provide insight in the
difference between types of IBD. This study investigates both unsupervised and
supervised learning. The unsupervised clustering did not should significant separation
between types of IBD. Hierarchical clustering is able to group most patients into 4 groups
but there is not significant different between groups. The following models where tested
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in order to decision which model to optimize; simple tree, medium tree, complex tree,
linear discriminant analysis, linear SVM, quadratic SVM, cubic SVM, boosted trees, and
bagged trees. Out of these models, linear discriminant analysis had the best accuracy with
81.0% followed closely by linear SVM which was a half percent lower. The SVM was
used for optimization for its adaptability and interpretability. The optimized SVM when
looking at both the endoscopy and histology data had the best accuracy with 82.7%.

2.4 Promteomic Mass Spectra
Pierre Geurts al et. perform a study in “Proteomic mass spectra classification
using decision tree-based ensemble methods” [13]. This study’s goal is to propose a
flexible method to analysis and learn from proteomic mass spectra with the hopes of a
framework that would be able to diagnosis multiple diseases. This study uses rheumatoid
arthritis and IBD as proof of concept with the hopes of expanding to other diseases.
Using rheumatoid arthritis and IBD have some shared characteristics and can treated with
the same medication [14]. This demonstrates that similar problem, but different problems
can be tackled by in a similar way. Geurts used the following models: single decision
tree, bagging, random forests, extra-trees, boosting, k-nearest neighbors, and support
vector machine. This paper uses a mass spectrometry data that generates protein profiles
from body fluids with 240 instances with both IBD patients and healthy controls. Their
experiments found that the model with the best error rate for the diagnosis of IBD was
achieved by extra-tree with a 10.02% error rate with the best discretization. This study
also investigates attribute importance ranking and biomarker selection. The attribute
selection by boosting (r = 1%) decreasing the error rate to 6.68%.
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2.5 Metagenomic Stool Sample
Federica Gigliucci al et. looks at metagenomic data from stool samples to identify
patients that are positive for Shiga toxin-producing Escherichia coli (STEC) in
“Metagenomic Characterization of the Human Intestinal Microbiota in Fecal Samples
from STEC-Infected Patients” [15]. The study shows that the subjects’ microbiota
underwent a significant change between subjects with and without the STEC infection
and even identify specific bacteria that are linked to the infection. This study has samples
from patients with diarrhea, patients after 2 weeks from the restoration of the normal
intestinal function, healthy subject, and patients with CD. The promising results of this
study set a precedence for analysis the metagenomic data of stool sample when
diagnosing diseases and infections that have major effect on the microbiota of a patient,
including CD.
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Chapter 3. Methodology and Dataset
These experiments use the Metagenomic dataset was collected and distributed by
the Inflammatory Bowel Disease Multi'omics Database (IBDMDB) [16] as a part of the
Integrative Human Microbiome Project (HMP2) [17]. Metagenome is the complete
sequencing of all genetic material in an environment. In this dataset, the environments are
the stool samples of each participant. The analysis of the metagenomic data of a stool
sample can give an insight into the microbiota of the participant without the having an
endoscopy, like a colonoscopy, performed. The study has 132 participants that are
collected from three pediatric facilities (Cincinnati Children’s Hospital, Massachusetts
General Hospital (MGH) Pediatrics, and Emory University Hospital) and two adult
facilities (MGH and Cedars-Sinai Medical Center). Multiple samples where taken from
the participants creating a dataset has 1338 instances with 599 CD diagnoses, 375 UC
diagnoses, and 364 nonIBD diagnoses as the control group of the study. The dataset has
1453 attributes with one class attribute after preprocessing. The dataset comes in two
part: metadata and metagenomic data.
Table 1: HMP2: Metagenomes Dataset
Dataset Name

Number of
Instances

Number of
Attributes

Number
of Classes

Class Distribution

HMP2: Metagenomes

1338

1454

3

CD – 599
UC – 375
nonIBD – 364

The metagenomic data in the dataset is sequences of bacteria, viruses, and other
microbes found in a participants’ stool sample while ignoring any of the human RNA for
the participant. This RNA sequence data is ran through on a Anadama pipeline to create
10

files that records the concentrations of the bacteria, viruses, and other microbes both as
specific species and larger classifications [16]. These concentrations values are broken by
according to the taxonomy of the microbes by not only looking at the concentration of
specific species but also kingdom, phylum, class, order, family, genus, and trinomen
(subspecies). There were about 540 different species identified but with filtering out of
any species with less than 0.01% abundance, they narrowed the study do to 109 species
[16].
The metadata contents attributes that were collected by having each participant
fill out a form asking questions about their health, recent diet, and general information
about themselves (age, sex, race, etc.). Some of these attributes were removed from the
dataset during preprocessing because they had the same value for every data point and/or
they were included for clerical purposes only and do not have any effect on the diagnosis
(ex: Name of the testing center). The attribute “Age at diagnosis” was also remove
because only the participants that have IBD have a diagnosis age. To allow for the both
the binary and ternary classifications, the diagnosis attributes must make a new dataset
where the diagnosis attributes was processed where any CD and UC labels to IBD, when
looking at IBD and non IBD. Two other datasets were created by removing rows for
either CD or UC, so comparisons between CD and nonIBD and between UC and
nonIBD.
The models that this paper focuses on is C4.5 decision tree, RIPPER, Decision
Table, Naïve Bayes, and k-nearest neighbor built-in models in WEKA. The ensemble
learning methods Bagging and Boosting are applied on C4.5 decision tree and RIPPER.
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Each model is ran with the default parameters in WEKA including using 10-fold crossvalidation for their validation unless otherwise specified.
The C4.5 decision tree (or J48 in WEKA) creates a binary tree that can also
ignore missing values [18]. It selected for this study because of its use in the simple
studies, its simplicity, and readability. The RIPPER algorithm (or JRip in WEKA) and
Decision Table were selected for their readability and to determine the effectiveness of
rule-based classifiers on this diagnosis problem. The JRip classifier or sometimes IREP
using reduced error pruning along with divide and conquer method of creating greedy
rule set one rule at a time [19]. The Decision table or sometimes Decision table majority
(DTM) is created by finding the optimal set of features that provide the highest accuracy
[20]. Naïve Bayes was selected because it is known for being applied to medical
diagnosis problems [21]. Naïve Bayes classifier provide a simple approach to calculating
probabilities by counting the frequency and combinations of values with the assumption
that the attributes are independent of the given class [18]. K-nearest neighbor (or IBk in
WEKA) was selected for its simplicity allows for easy implementation and explanation to
those who have not used the model before. When classifying new data points, k-nearest
neighbor determines what the closer existing data points (or neighbors) are and determine
the new point class based on the classes of its neighbors [22].
The Bagging and Boosting ensemble learning models were picked because they
are two of the most common ensemble methods used and to draw comparison with the
related studies which also used bagging and boosting. Bagging (also known as bootstrap
aggregating) generates multiple versions of the selected method using bootstrap replicates
to make an aggregated predictor [23]. Boosting (or AdaBoost in WEKA) is used to
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“boost” the accuracy of other algorithm by running the classifier multiple times with
various distributions over the training data and then combines the runs to make a single
composite classifier [24].
The decision tree and RIPPER are especially focused on due to their better
readability which allows for additional information beyond their statistics (accuracy,
ROC, etc.). The models can also be evaluated by investing if the models created make
logical sense with the attributes used. Also, it allows users that might not be as familiar
with data models, such as medical professions, to understand the model while using it for
diagnosis. Other models such as neural networks were considered for this paper but since
the dataset has discrete and non-discrete attributes, models like neural networks are not
suited for this type of dataset.
All of the models were tested on five subsets of the attributes: all, metagenomic,
meta, race, and sex. These subsets help to determine the importance of varies attributes in
the different classification problems and in the varies models used. The attribute race was
selected because it is known risk factor. However, sex was selected because females are
more likely to have CD even if the sex patient is not a specific risk factor [4]. The subset
all consists of all the attribute not remove with preprocessing, metagenomic consists only
of the numeric concentrations values from the metagenomic data and the diagnosis,
metadata consists of all attributes from the metadata, race consists of the metagenomic
values, the diagnosis, and race, and sex consists of the metagenomic values, the
diagnosis, and sex. The metadata subset is unlikely to provide a good diagnostic tool, but
it may lead to a better understanding of what attributes from the metadata are important
in the diagnosis problem.
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Chapter 4. Binary Classification: IBD and nonIBD
This section discusses the binary classification of instances as either IBD or
nonIBD. This binary classification focus on whether a patient has IBD, in general, so
future tests would have to be performed to given them a more specific diagnosis. This
section will compare accuracies against those obtained by Geurt’s study [13]. A
comparison is not been made to Mossotto’s study because the diagnosis is only between
CD and UC without healthy controls [12].

4.1 Initial Results
Figure 1 shows a comparison between the different models on the different
subsets on the IBD/nonIBD dataset. The dataset consists of 974 instances of IBD and 364
instances of nonIBD.
4.1.1 Decision Table
At first glance, it appears that the decision table using the all subset is the best
model option for the IBD and nonIBD model. The decision table has good readability and
has the best accuracy of the models and subsets, but the rules created show that it is not a
good option for this dataset. The table created with the all use following attributes:
“consent_age”, “Immunosuppressants (e.g. oral corticosteroids)”, “In the past 2 weeks
have you used an oral contrast”, “General wellbeing”, “Bowel frequency during the day”,
and "Haemophilus pittmaniae”. Generally a smaller decision table usually means a better
decision table, but asking for a patients age, medications they are using, their general
wellbeing, and looking at concentration of one bacteria, the is not going to be enough
information to diagnosis someone with a complex disease like IBD. The decision table
14

using the metadata subset also has quite high accuracy, but it uses the same attributes as
the all subset minus the "Haemophilus pittmaniae” attribute. The decision table has more
reasonable attribute selection for the other subsets, however, these tables are not as
attractive as a choice because they have lower accuracy than the models with similar
accuracy.
4.1.2 K-Nearest Neighbor
After the decision table, k-nearest neighbor has high accuracy in comparison to
other models. The k-nearest neighbor with all the different subsets of this dataset also
outperformed the k-nearest neighbor from Geurts’s study which has an error rate of
20.21% (or accuracy of 79.79%) [13]. While the accuracy of the model is the highest, the
model has low readability. While the concept of nearest neighbor is simple and easy for
people to understand, it is hard to actually gain additional information from the model.
This means that no addition information can be gathered from the model which in turn
means fewer medical professionals would trust the model’s diagnosis.
4.1.3 Naïve Bayes
The Naïve Bayes model does not perform very well for all the different subsets
with the exception of the metadata subset. This model appears to not be equipped to work
with the metagenomic abundance data because the accuracy of this model increases with
the two subsets that include the metadata (all and metadata subsets). However, the
specific metadata attributes of sex and race appear to have no effect on the model since
the accuracy of the metagenomic, sex, and race subsets are the same. Despite the Naïve
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Bayes model being popular for medical diagnosis problems, it is not a good fit for this
specific problem.
4.1.4 C4.5 Decision Tree
The C4.5 decision tree has the best accuracy when classifying IBD and nonIBD
when looking at the sex subset. After the decision table and k-nearest neighbor models,
C4.5 decision tree has the highest accuracy but only when using the sex subset. The C4.5
decision tree is quite consistent across the different subsets with the exception of the
metadata subset, since the accuracy between subset has less than a percent difference.
The good readability of the decision tree also makes this model more trusted because the
user knows why the model has made its prediction. The C4.5 decision using the sex
outperforms the single tree in Geurts’s study, with a 26.67% error rate (or accuracy of
73.3%) [13], and it also outperforms a colonoscopy by 3.75% [10]. However, the
accuracy of the best method in Geurts’ study which is using attribute selection by
boosting (r = 1%) outperformed the C4.5 decision tree but only by about 0.57% [13].
4.1.5 RIPPER
The RIPPER algorithm also has merit for the classification between IBD and
nonIBD. When using the all subset, the accuracy is the highest after the decision table
and k-nearest neighbor. Since the RIPPER is a rule-based classifier, the readability is
excellent even for individual with little to no experience with the model itself. The size of
the RIPPER algorithm increases its attractiveness in comparison with the C4.5 decision
tree. The RIPPER algorithm has 11 rules while the C4.5 decision tree has a size of 89
with 45 leaves. The receiver operating characteristic area (ROC area) of the RIPPER
algorithm (90.4%) is higher than the ROC area of the C4.5 decision tree (89.4%).
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Because of these factors, RIPPER algorithm is a better model for the IBD and nonIBD
classification problem, especially with it still outperforming the colonoscopy by 3.45%
[10].
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Figure 1: IBD/nonIBD Classification Accuracy Chart

4.2 Ensemble Learning
The ensemble methods improved the accuracy of both the C4.5 decision tree and
the RIPPER algorithm. The increase between the single models and the bagging methods
has a similar increase for both models with the RIPPER algorithm having a larger
increase. The decision tree has an increase of about 3.66% while the RIPPER algorithm
of about 4.26% while using the bagging method. The boosting, however, has a larger
impact on the RIPPER algorithm’s accuracy then the accuracy for the decision tree (with
about 6.05% and 4.71% change respectively). This study’s bagging and boosting for trees
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outperform Geurt’s study who’s bagging tree error rate is 16.25% (or accuracy of
83.75%) and boosting tree’s error rate is 11.46% (or accuracy of 88.54%) [13].
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Figure 2: IBD/nonIBD Ensemble Methods Accuracy Chart

4.3 Accuracy Improvement
In an attempt to improve the accuracy of the RIPPER algortihm, the number of
optimzation runs performed during the optimization stage for both the single model and
for ensemble learning. The default number of optimzation runs in WEKA is 2.
4.3.1 Best Model - RIPPER
We see little change when only a few extra runs are added to the optimization
stage. When changed from 2 to 3, 4, or 5, the accuracy, false positive rate, and ROC
Area only changes by less then a percent and with the addition of one rule. However, if
the number of optimzation runs is increased to 10 or 20, the accuracy and ROC Area is
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inceased significant and false positive rate decreases significantly. Using 10 runs has a
sightly smaller false positive rate then using 20 runs but using 20 runs has better accuracy
then using 10 runs (by 0.23%) and has two less rules which decrease the complex of the
rule set. For different optimization runs performed, 20 runs is the best choice for binary
classification. Using 20 optimization runs with the RIPPER algorithm outperforms the
accuracy of a colonoscopy by almost 5% [10].
Table 2: RIPPER Optimization for IBD/nonIBD Classification
Number of
Optimizations Runs

Accuracy

FP Rate

ROC Area

Number of Rules

2

92.45%

12.1%

90.5%

11

3

92.45%

11.9%

90.5%

12

4

91.93%

12.3%

90.2%

12

5

92.90%

11.4%

90.8%

12

10

93.72%

8.4%

93.0%

12

20

93.95%

8.5%

93.0%

10

4.3.2 Improved Ensemble Learning
To continue improving accuracy, the RIPPER algortihm with 20 optizimation
runs is used with the ensemble learning methods of bagging and boosting. As show
above, bagging improves the 2 run RIPPER algortihm by about 4.26% and boosting
improves it by 6.05%. From the 2 run RIPPER alogrithm, there is an increase of about
3.36% when using bagging and an increase of about 5.38% when using boosting on the
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20 run RIPPER algorithm. While the ensemble learning with the increased number of
optizimation runs has a high accuracy, it has a smaller increase of the accuracy.
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Figure 3: IBD/nonIBD Improved RIPPER Ensemble Accuracy
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Chapter 5. Binary Classification: CD and nonIBD
This section discusses the binary classification of instances as either CD or
nonIBD. This binary classification focus on whether a patient has CD, so future tests
would have to be performed to see if a patient has UC if the test comes up negative. This
section will compare accuracies against those obtained by Geurt’s study but keep in mind
that their study is comparing IBD and nonIBD [13]. A comparison is not been made to
Mossotto’s study because the diagnosis is only between CD and UC without healthy
controls [12].

5.1 Initial Results
Figure 4 shows a comparison between the different models on the different
subsets on the CD/nonIBD dataset. The dataset consists of 599 instances of CD and 364
instances of nonIBD.
5.1.1 Decision Table
At first glance, it appears that the decision table using the all subset is the best
model option for the CD and nonIBD model. The decision table has good readability and
has the best accuracy of the models and subsets, but the rules created show that it is not a
good option for this dataset. The table created with the all use following attributes:
“consent_age”, “Have you ever had bowel surgery?” “General wellbeing”, and
“Bacteroides dorei”. Generally a smaller decision table usually means a better decision
table, but asking for a patients age, whether they have had bowel surgery, their general
wellbeing, and looking at concentration of one bacteria, the is not going to be enough
information to diagnosis someone with a complex disease like IBD. The decision table
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using the metadata subset also has quite high accuracy, but it uses the same attributes as
the all subset minus the " Bacteroides dorei” attribute. The decision table has more
reasonable attribute selection for the other subsets, however, these tables are not as
attractive as a choice because they have lower accuracy than the models with similar
accuracy.
5.1.2 K-Nearest Neighbor
After the decision table, k-nearest neighbor has high accuracy in comparison to
other models. The k-nearest neighbor with all the different subsets of this dataset also
outperformed the k-nearest neighbor from Geurts’s study which has an error rate of
20.21% (or accuracy of 79.79%) [13]. While the accuracy of the model is the highest, the
model has low readability. Due to the difficulty of reading the k-nearest neighbor, no
addition information can be gathered from the model which in turn means fewer medical
professionals would trust the model’s diagnosis.
5.1.3 Naïve Bayes
The Naïve Bayes model does not perform very well for all the different subsets
with the exception of the metadata subset. This model appears to not be equipped to work
with the metagenomic abundance data because the accuracy of this model increases with
the two subsets that include the metadata (all and metadata subsets). However, the
specific metadata attributes of sex and race appear to have no effect on the model since
the accuracy of the metagenomic, sex, and race subsets are the same. Despite the Naïve
Bayes model being popular for medical diagnosis problems, it is not a good fit for this
specific problem.
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5.1.4 C4.5 Decision Tree
The C4.5 decision tree has the best accuracy when classifying CD and nonIBD
when looking at the all subset. After the decision table and k-nearest neighbor models,
C4.5 decision tree has the highest accuracy but only when using the all subset.
The C4.5 decision tree is quite consistent across the different subsets with the exception
of the metadata subset, since the accuracy between subset has less than a percent
difference. The good readability of the decision tree also makes this model more trusted
because the user knows why the model has made its prediction. The C4.5 decision tree
using the all outperforms the single tree in Geurts’s study by about 17.77% [13], and it
also outperforms a colonoscopy by 2.07% [10]. However, the accuracy of the best
method in Geurts’ study which is using attribute selection by boosting (r = 1%)
outperformed the C4.5 decision tree but only by about 1.41% [13].
5.1.5 RIPPER
The RIPPER algorithm also has merit with the classification between IBD and
nonIBD. When using the all subset, the accuracy is the highest after the decision table
and k-nearest neighbor. Since the RIPPER is a rule-based classifier, the readability is
excellent even for individual with little to no experience with the model itself. The size of
the RIPPER algorithm increases its attractiveness in comparison with the C4.5 decision
tree. The RIPPER algorithm has 11 rules while the C4.5 decision tree has a size of 85
with 48 leaves. Because of these factors, RIPPER algorithm is a better model for the CD
and nonIBD classification problem, especially with it still outperforming the colonoscopy
by 1.55% [10].
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Figure 4: CD/nonIBD Classification Accuracy

5.2 Ensemble Learning
The ensemble methods improved the accuracy of both the C4.5 decision tree and
the RIPPER algorithm. The boosting method performs better than bagging method. The
C4.5 decision tree has a larger accuracy than RIPPER when using the boosting method,
but the RIPPER algorithm performs better than C4.5 decision tree in the bagging method.
In the bagging method, the decision tree has an increase of about 3.32% while the
RIPPER algorithm of about 5.82%. The boosting, however, has a larger impact on the
RIPPER algorithm’s accuracy then the accuracy for the decision tree (with about an
7.17% and 6.65% respectively), but the C4.5 decision tree has larger accuracy then the
RIPPER algorithm. This study’s bagging and boosting for trees outperform Geurt’s study
by about 10.64% and outperforms the boosting by about 9.18% [13].
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Figure 5: CD/nonIBD Ensemble Methods Accuracy

5.3 Accuracy Improvement
In an attempt to increase the accuracy of the C4.5 decision tree, the confidence
factor related to pruning the tree has been changed. The default value in WEKA for the
confidence factor is 0.25. The decrease of this number increases the amount of pruning.
In this experiment, the confidence factor will only be lowered to guard against
overfitting.
5.3.1 Best Model – C4.5 Decision Tree
Very little change occurs in the accuracy when the confidence factor is decreased.
The accuracy does increase between the confidence factor 0.25 and 0.20 or 0.25and 0.15.
The decision trees with confidence factors 0.20 and 0.15 have the same accuracy with
91.1734%. The confidence factor of 0.15 provides a slightly better tree with the ROC
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Area increasing by 0.1%, the number of leaves decreasing by 7, and the size decreases by
9. The confidence factors of 0.10 and 0.05 both have a decrease in accuracy with 0.05
having the worse accuracy of the two trees created. The best accuracy made by the
Table 3: C4.5 Decision Tree Optimization for CD/nonIBD Classification
Confidence Factor

Accuracy FP Rate ROC Area

Number of Leaves

Size

0.25

91.07 %

10.2%

93.1%

48

85

0.20

91.17%

10.0%

93.0%

48

85

0.15

91.17%

9.9%

93.1%

41

76

0.10

90.97%

10.4%

93.3%

41

76

0.05

90.76%

10.7%

93.1%

41

76

5.3.2 “Improved” Ensemble Learning
In an attempt to increase the accuracy of the ensemble learning, the confidence
factors of 0.20 and 0.15 are used on the C4.5 decision trees with boosting and bagging
methods. Despite the increase in accuracy that is seen when using the confidence factor
0.20 and 0.15, the ensemble methods had a decrease in accuracy in comparison to the
default confidence factor. This is likely due to the decrease in size of the various trees
created by when performing the bagging and boosting methods. The larger confidence
factor produces the better accuracy for both the boosting and bagging methods.
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Figure 6: CD/nonIBD “Improved” C4.5 Ensemble Accuracy
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Chapter 6. Binary Classification: UC and nonIBD
This section discusses the binary classification of instances as either UC or
nonIBD. This binary classification focus on whether a patient has UC, so future tests
would have to be performed to see if a patient has CD if the test comes up negative. This
section will compare accuracies against those obtained by Geurt’s study but keep in mind
that their study is comparing IBD and nonIBD [13]. A comparison is not been made to
Mossotto’s study because the diagnosis is only between CD and UC without healthy
controls [12].

6.1 Initial Results
Figure 5 shows a comparison between the different models on the different
subsets on the UC/nonIBD dataset. The dataset consists of 374 instances of UC and 364
instances of nonIBD.
6.1.1 Decision Table
At first glance, it appears that the decision table using the all subset is the best
model option for the CD and nonIBD model. The decision table has good readability and
has the best accuracy of the models and subsets, but the rules created show that it is not a
good option for this dataset. The table created with the all use following attributes:
“Starch (white rice bread pizza potatoes yams cereals pancakes etc.) ”, “General
wellbeing”, “Bowel frequency during the day”, “Eggerthella”, “Lactobacillus” and
“Haemophilus pittmaniae”. Generally a smaller decision table usually means a better
decision table, but asking for a patients age, whether they have had bowel surgery, their
general wellbeing, and looking at concentration of one bacteria, the is not going to be
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enough information to diagnosis someone with a complex disease like IBD. The decision
table using the metadata subset also has quite high accuracy, but it uses the same
attributes as the all subset minus the " Bacteroides dorei” attribute. The decision table has
more reasonable attribute selection for the other subsets, however, these tables are not as
attractive as a choice because they have lower accuracy than the models with similar
accuracy.
6.1.2 K-Nearest Neighbor
After the decision table, k-nearest neighbor has high accuracy in comparison to
other models. The k-nearest neighbor with all the different subsets of this dataset also
outperformed the k-nearest neighbor from Geurts’s study which has an error rate of
20.21% (or accuracy of 79.79%) [13]. While the accuracy of the model is the highest, the
model has low readability. Due to the difficulty of reading the k-nearest neighbor, no
addition information can be gathered from the model which in turn means fewer medical
professionals would trust the model’s diagnosis.
6.1.3 Naïve Bayes
The Naïve Bayes model does not perform very well for all the different subsets
with the exception of the metadata subset. This model appears to not be equipped to work
with the metagenomic abundance data because the accuracy of this model increases with
the two subsets that include the metadata (all and metadata subsets). However, the
specific metadata attributes of sex and race appear to have no effect on the model since
the accuracy of the metagenomic, sex, and race subsets are the same. Despite the Naïve
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Bayes model being popular for medical diagnosis problems, it is not a good fit for this
specific problem.
6.1.4 C4.5 Decision Tree
The C4.5 decision tree has the best accuracy when classifying UC and nonIBD
when looking at the all subset. After the decision table and k-nearest neighbor models,
C4.5 decision tree has the highest accuracy but only when using the all subset.
The C4.5 decision tree is quite consistent across the different subsets with the exception
of the metadata subset, since the accuracy between subset has less than a percent
difference. The good readability of the decision tree also makes this model more trusted
because the user knows why the model has made its prediction. The C4.5 decision tree
using the all outperforms the single tree in Geurts’s study by about 17.74% [13], and it
also outperforms a colonoscopy by 2.07% [10]. However, the accuracy of the best
method in Geurts’ study which is using attribute selection by boosting (r = 1%)
outperformed the C4.5 decision tree but only by about 2.25% [13].
6.1.5 RIPPER
The RIPPER algorithm also has merit with the classification between IBD and
nonIBD. When using the all subset, the accuracy is the highest after the decision table
and k-nearest neighbor. Since the RIPPER is a rule-based classifier, the readability is
excellent even for individual with little to no experience with the model itself. The size of
the RIPPER algorithm increases its attractiveness in comparison with the C4.5 decision
tree. The RIPPER algorithm has 9 rules while the C4.5 decision tree has a size of 42 with
22 leaves. However, the RIPPER algorithm only outperforms the colonoscopy by about
0.58% [10].
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Figure 7: UC/nonIBD Classification Accuracy

6.2 Ensemble Learning
The ensemble methods improved the accuracy of both the C4.5 decision tree and
the RIPPER algorithm. The boosting method performs better than bagging method. The
RIPPER has a larger accuracy than the C4.5 decision tree for both the boosting and
bagging method. In the bagging method, the decision tree has an increase of about 4.74%
while the RIPPER algorithm of about 9.07%. The boosting, however, has a larger impact
on the RIPPER algorithm’s accuracy then the accuracy for the decision tree (with about
9.47% and 6.90% respectively). This study’s bagging and boosting for trees outperform
Geurt’s study by about 10.64% and outperforms the boosting by about 9.18% [13].
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Figure 8: UC/nonIBD Ensemble Methods Accuracy

6.3 Accuracy Improvement
In an attempt to increase the accuracy of the C4.5 decision tree, the confidence
factor related to pruning the tree has been changed. The default value in WEKA for the
confidence factor is 0.25. The decrease of this number increases the amount of pruning.
In this experiment, the confidence factor will only be lowered to guard against
overfitting.
6.3.1 Best Model – C4.5 Decision Tree
There is no change in accuracy, false positive rate, size, or number of leaves
between confidence factors of 0.25, 0.20, and 0.15, however, 0.20 and 0.15 have slightly
increased ROC Area (by 0.01%). There is a decrease in accuracy by about 0.41%, a
decrease in the ROC Area to 91.4%, and an increase in the false positive rate by 0.4%
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when using the confidence factor 0.10. The confidence factor 0.05 provides a slightly
better tree then using 0.15 with an increase of about 0.13% in accuracy and 0.4% in ROC
Area and decrease in the false positive rate (by about 0.1%), the size, and number of
leaves.
Table 4: C4.5 Decision Tree Optimization for UC/nonIBD Classification
Confidence Factor

Accuracy FP Rate ROC Area

Number of Leaves

Size

0.25

91.07 %

8.9%

91.8%

22

42

0.20

91.07 %

8.9%

91.9%

22

42

0.15

91.07 %

8.9%

91.9%

22

42

0.10

90.66%

9.3%

91.4%

22

42

0.05

90.79%

9.2%

91.8%

20
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6.3.2 “Improved” Ensemble Learning
The confidence factors 0.20 and 0.15 were used to attempt to increase the
accuracy of the ensemble learning methods. There was no increase in accuracy seen by
the boosting or bagging methods when using either 0.20 or 0.15. Boosting sees no change
in accuracy between using confidence factor 0.25 and 0.15 but there is a decrease in
accuracy by about 0.54%. Bagging sees a decrease in accuracy of about 0.14% when
using 0.20 and a decrease of about 0.41% when using 0.15.
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Figure 9: UC/nonIBD “Improved” C4.5 Ensemble Accuracy
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Chapter 7. Ternary Classification: CD, UC, and nonIBD
This section discusses the ternary classification od instances as CD, UC or
nonIBD. While the accuracy of the prediction does decreases but a ternary classification
allows for the model give a more specific diagnosis between the specific types for IDB.
In this section a comparison between the study and the study performed by Mossotto and
the study performed by Geurts. Keep in mind that both studies are dealing with binary
classifications and that Geurts’ study is IBD vs nonIBD while the Mossotto’s study is CD
vs UC [12] [13].

7.1 Initial Results
Figure 6 shows a comparison between the different models on the different
subsets on the ternary dataset. The dataset consists of 599 instances of CD, 375 instances
of UC, and 364 instances of nonIBD.
7.1.1 Decision Table
At first glance, it appears when using the all subset is the best model option for
the ternary classification model, but just like before the rules created show that it is not a
good option for this dataset. The table created with the all use following attributes:
“consent_age”, “General wellbeing”, “Bowel frequency during the day”, “Bacteroides
fluxus”, and “Bacteroides sp 4 3 47FAA”. Generally a smaller decision table usually
means a better decision table, but asking for a patients age, their general wellbeing, the
frequency of bowel movements during day and looking at concentration of two bacteria,
the is not going to be enough information to diagnosis someone with a complex disease
like IBD. The decision table using the metadata subset also has quite high accuracy, but
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it uses the following attributes: “In the past 2 weeks have you had diarrhea?”, “General
wellbeing”, “Arthralgias”, and “Bowel frequency during the day”. These attributes are
also not enough to diagnosis a complex disease. The decision table has more reasonable
attribute selection for the other subsets, however, these tables are not as attractive as a
choice because they have lower accuracy than the models with similar accuracy.
7.1.2 K-Nearest Neighbor
The k-nearest neighbor has the second highest accuracy after the decision table.
Due to the poor readiability of the model it is hard to trust with a task such as medical
diagnosis especially when there are other models with signicantly high accuracy that are
easily readiable. The k-nearest neighbor from all the subsets outperformed the k-nearest
neighbor from Geurts’s study. The all subset outperformed Geurts’ study by about
16.77% [13].
7.1.3 Naïve Bayes
The Naïve Bayes model does not perform very well for all the different subsets
with the exception of the metadata subset. This model appears to not be equipped to work
with the metagenomic abundance data because the accuracy of this model increases with
the two subsets that include the metadata (all and metadata subsets). However, the
specific metadata attributes of sex and race appear to have no effect on the model since
the accuracy of the metagenomic, sex, and race subsets are the same. Despite the Naïve
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Bayes model being popular for medical diagnosis problems, it is not a good fit for this
specific problem.
7.1.4 RIPPER
The RIPPER algorithm has the best accuracy for ternary classification when using
the all after the decision table and k-nearest neighbor. The RIPPER algorithm continues
to provide a small resulting model than the C4.5 decision with the RIPPER algorithm
creating 11 rules and the C4.5 decision tree with the best accuracy (using the race subset)
has a size of 168 with 89 leaves. The RIPPER algoritm outperformed the optimizied
SVM from Mossotto’s study be about 7.7% [12] and also outperformed colonoscopy’s
accurracy by about 3.6% [10]. However, the accuracy of the best method in Geurts’ study
which is using attribute selection by boosting (r = 1%) outperformed the C4.5 decision
tree but only by about 0.72% [13].
7.1.5 C4.5 Decision Tree
While the C4.5 decision tree is not the best option for the ternary classification
problem, it still has significant merit. The accuracy of the decision tree surpasses the
RIPPER algorithm when using the metagenomic, race, and sex subsets with the best
accuracy using the race subset. The readability of the C4.5 decision tree still makes it an
attractive model for a diagnosis problem; however, the larger size and the lower accuracy
means it is still not a good as a choose as the RIPPER algorithm. The RIPPER algorithm
is still the better of the two models but the C4.5 decision tree is still an attractive model
that should still be investigated further, especially because of itself result when looking at
the CD/nonIBD and the UC/nonIBD classification problems. This study has better
accuracy in comparison to Mossotto’s study by about 10.47% for the single tree model
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and the Guerts’ study by 7.15% [12].

Ternary Classification Accuracy
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Figure 10: Ternary Classification Accuracy
7.2 Ensemble Learning
The ensemble methods improved the accuracy of both the C4.5 decision tree and
the RIPPER algorithm when using the all subset. The bagging model increases the
accuracy of the single method with about 9.49% increase for the decision tree and about
2.99% increase for the RIPPER algorithm. The boosting method also has a larger effect
on the decision tree with an increase in acurracy of about 12.33%, while boosting
increased the accuracy of the RIPPER algorithm by about 4.56%. This study’s bagging
and boosting for trees outperform Mossotto’s study who’s bagging tree accuracy of
77.6% and boosting tree’s accuracy of 74.8% [12] and Guert’s study who’s bagging tree
with an error rate of 13.36% (or accuracy of 86.64%) and boosting tree’s error rate of
10.44% (or accuracy of 89.56%) [13].
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Figure 11: Ternary Ensemble Method Accuracy

7.3 Accuracy Improvement
In an attempt to improve the accuracy of the RIPPER algortihm, the number of
optimzation runs performed during the optimization stage for both the single model and
for ensemble learning. The default number of optimzation runs in WEKA is 2.
7.3.1 Best Model - RIPPER
For ternary classification, the increase of optimization runs generally increases the
accuracy of the rule set until too many runs are performed. The number of rules created
also have curve that peaks around 5 runs. Running 4 and 5 runs returns the accuracy but
when performing the 5 runs, the false positive rate increase by 0.1% and number of rules
created increases by 2 but the ROC Area increases by 0.1%. When 20 runs are peformed,
number of rules does decrease but it also comes with a decrease in accuracy, an increase
39

in false positive rate, and a decrease in ROC Area.
Table 4:RIPPER Optimization for Ternary Classification
Number of
Optimizations Runs

Accuracy

FP Rate

ROC Area

Number of Rules

2

92.60%

4.5%

95.4%

14

3

92.75%

4.5%

95.5%

14

4

93.27%

4.2%

95.8%

15

5

93.27%

4.3%

95.9%

17

10

93.35%

4.2%

96.0%

16

20

92.83%

4.5%

95.2%

15

7.3.2 Improved Ensemble Learning
To continue improving accuracy, the RIPPER algortihm with 10 optizimation
runs is used with the ensemble learning methods of bagging and boosting. As show
above, bagging improves the 2 runs RIPPER algortihm by about 5.83% and boosting
improves it by 7.40%. From the 2 run RIPPER alogrithm, there is an increase of about
2.54% when using bagging and an increase of about 4.86% when using boosting on the
20 run RIPPER algorithm. While the ensemble learning with the increased number of
optizimation runs has a high accuracy, it has a smaller increase of the accuracy. The
bagging method has very little change in accuracy with only around a 0.3% change
between 2 runs and 10 runs.
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Figure 12: Ternary Improved RIPPER Ensemble Accuracy
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Chapter 8. Discussion
8.1 Change in Bacteria Abundances
8.1.1 Genus Coprococcus
The root of the decision trees for all of the subset, exclude the metadata subset,
Coprococcus eutactus for both IBD/nonIBD and ternary classification. While
Coprococcus eutactus is not the root of the CD/nonIBD tree, it is located on the second
level. Coprococcus eutactus is not found in the decision tree created for UC/nonIBD. The
bacterica Coprococcus comes is found in the rules created by the RIPPER algorithm for
the IBD/nonIBD problem. The placement of this species of bacteria makes senses given
knowledge about its genus. Studies show that the abundance of genus Coprococcus
decrease when a patient has IBD [25] [26]. When Coprococcus eutactus is great than
zero percent of the total microbiota the vast majority of the instances on that side of the
tree are diagnosis nonIBD. While the genus Coprococcus has a decrease in abundance for
IBD patients, my research shows that it may have a more important role in CD then UC.
Coprococcus is also found to help protect patients against colon cancer which IBD
patients are at a higher risk of getting [27].
8.1.2 Genus Alistipes
It also appears that the bacteria genus Alistipes is important in the classification of
IBD. All of the rules created by the RIPPER algorithm using the genus Alistipes classify
as nonIBD if the abundance of bacteria is higher than a specific point. Multiple bacteria
species in this genus also appear in the varies decision trees created. This genus appears
in at least on rule creates by the RIPPER algorithm for all four of the classification
problems. The genus Alistipes appears in the trees created by all the classification
42

problem except UC/nonIBD, with it appearing relatively high in the IBD/nonIBD tree.
This would indicate that this genus may have a stronger link the CD then to UC. This
pattern follows because multiple studies so that multiple bacteria species from this genus
(alistipes finegoldii, alistipes putredinis, and alistipes shahii) decrease in amount and/or
growth rate in people with IBD in comparison to healthy controls [28] [29]. All of the
previously mention bacteria species have been specifically seen as a part of some of
model created.
8.1.3 Genus Bacteroides
The bacteria genus Bacteroides is the genus that is found most often seen in the
rules created by the RIPPER algorithm and the nodes of the C4.5 decision trees across all
four classification problems. This observation does make sense because this genus has
been shown to have a strong link to IBD [30]. Unlike the previous bacteria genera
discussed, there is not a set pattern seen in the rule for an increase or decrease of
abundance for any class in particular. This may be caused by different species in the
genus acting in different ways then each other. However, in a meta-analysis performed by
Yingting Zhou and Fachao Zhi, it was found that different studies have shown
contradictory results when looking at genus Bacteroides and IBD. In the FISH study and
conventional culture studies they looked at, CD and UC patient are shown to higher
levels of Bacteroides then healthy controls, but in the Real-Time Quantitative PCR
studies, CD and UC patient are shown to lower levels of Bacteroides then healthy
controls [30]. Yingting Zhou and Fachao Zhi theorized that this difference may be caused
difference in ethnicity because the FISH study and conventional culture studies received
samples from mostly European patient while the Real-Time Quantitative PCR studies
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were mostly Asian patients. This may explain the variety of levels seen in this study with
a wider variety of different ethnic groups.
8.1.4 Specific Species
Other bacteria that are known to decrease in abundance with patient diagnosed
with IBD are Clostridium leptum and Faecalibacterium prausnitzi [31]. They are both
present in the rules created by the RIPPER algorithm for ternary classification (with the
all subset) and when the abundance is greater than or equal to a specific point then they
are classified as nonIBD. This follows from a decrease seen in IBD patients. However, in
the C4.5 decision tree for ternary classification (with the all subset), Clostridium leptum
is not present at all and the relation of Faecalibacterium prausnitzi between IBD patient
and nonIBD is flipped. When the abundance is higher than a specific point then they are
classified as UC and nonIBD when less than or equal to that specific point.

8.2 Race and Ternary Classification
As previously stated, the ethnicity/race of a person can increase the chances of
IBD [6]. However, race seems to play a bigger role when diagnosis on a ternary
classification then IBD/nonIBD, CD/nonIBD, and UC/nonIBD classification. The best
accuracy for the C4.5 decision tree on the ternary classification is when using the race
subset. It increases the accuracy by about 3 percent when using the all subset and about 6
percent when using the metagenomic subset. This increase can also be seen in the
RIPPER algorithm. While the accuracy for RIPPER using the race subset is not larger
than the accuracy of the all subset, there is little under a 3 percent increase in comparison
to the metagenomic subset. In contrast, the accuracy between the all, metagenomic and
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race do not even differ by a single percent when using the C4.5 tree with metagenomic
subset having the best accuracy. The RIPPER algorithm has more variability with the all
subset have about 2 percent higher than either the metagenomic or race subsets. The
metagenomic and race subsets differ less than a percent. This relation to the race attribute
is not seen in the UC/nonIBD problem and can only be seen in the CD/nonIBD problem
in the accuracies of the RIPPER algorithm (by about 0.83%). This leads one to believe
that the attribute race has more importance to distinguishing between CD and UC then
diagnosing IBD itself or diagnosing one or the other individually, with slightly more
importance to CD diagnosis.

8.3 Study Comparison
When using the RIPPER algorithm with the all subset consistently suppressed the
accuracy of diagnoses from the other studies discussed in the related work. It is likely for
two reasons. The first reason is the size of the dataset is significantly larger than in
previous studies. The Metagenomic dataset used for this study is about 60% larger than
the two related studies discussed earlier in this paper combined. Even the smallest
classification (UC/nonIBD) is about 29% larger than the other two studies combined.
With a larger dataset, the models created will be better trained models. The second reason
is the type of data. While the protein profiles generated by the mass spectrometry, does
provide a diagnose data for a disease, metagenomic data from a stool sample provides
information specific to IBD and patient’s microbiota. This shifts the focus specifically on
the abundancies of bacteria in a patient’s GI tract provides insight specifically where IBD
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affects. Of the these two reason is the more significant of the two reasons is the larger
size of the dataset.
This study also allows for the investigation of ternary classification of IBD. The
previous related studies only looks at binary classification (either IBD vs nonIBD or CD
vs UC). This study also investigates multiple binary classification problems
(IBD/nonIBD, CD/nonIBD, and UC/nonIBD). Looking at both of these two avenues
provides a better look into the complexity of the larger diagnosis problem. The ternary
classification continued to outperform the accuracy of the previous studies even with the
added complexity with the addition to a third class. The discussion of the different
classification problems in this study is investigated further in the next section.

8.4 Classification Type Comparison
As stated before, the ternary classification, in general, is going to have lower
accuracy then that of the binary classification counterparts. One model, however, does
not follow this tendency, which is the RIPPER algorithm. The IBD/nonIBD accuracy is
similar to the Ternary RIPPER algorithm with the CD/nonIBD and UC/nonIBD trailing
behind by about 1%. This section will draw a further comparison between IBD/nonIBD
and Ternary classification and further comparison between CD/nonIBD and UC/nonIBD.
8.4.1 IBD/nonIBD vs Ternary
The RIPPER algorithm when using the all dataset has a very slight increase (by
0.1495% with two more instances properly classified) in its accuracy between
IBD/nonIBD and ternary classification when using the default parameters. Not only is
there an increase in accuracy but allows the precision (by 0.2%), recall (by 0.1%), F-
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measure (by 0.2%), MCC (by 7.7%), ROC area (by 4.9%), and (Precision Recall) PRC
Area (by 0.6%) and a decrease in the false positive rate by 7.6%. This allows the ternary
classification to be used for the RIPPER algorithm without losing accuracy but gaining
more information for a more specific diagnosis between CD, UC, and nonIBD.
Table 5: RIPPER Performance Metrics for Different Optimization Runs
TP
Rate

FP
Rate

Precision Recall

F-Measure

MCC

ROC
Area

PRC
Area

IBD/N
O=2

92.5% 12.1%

92.4%

92.5%

92.4%

80.8%

90.5% 90.6%

IBD/N
O = 20

93.9%

8.5%

94.0%

93.9%

94.0%

84.8%

93.0% 92.6%

Ternary 92.6%
O=2

4.5%

92.8%

92.6%

92.6%

88.5%

95.4% 91.2%

Ternary 93.3%
O = 10

4.2%

93.5%

93.3%

93.4%

89.6%

96.0% 92.3%

This increase in accuracy of the ternary classification does not continue to hold
when the number of optimizations runs (O) is adjusted (Table 5). The binary
classification accuracy increases and suppresses the ternary classification but only by a
fraction of a percent. However, the ternary classification still improves upon the binary
classification with cutting the false positive rate in half and with and increase in the MCC
and the ROC Area. With the difference in accuracy only being less than a percentage
point, the decrease of the false positive rate by 4.3% still makes the ternary classification
RIPPER algorithm the superior choice.
This flip in accuracy does not continue for the bagging technique. The ternary
classification accuracy for bagging trailing the binary classification by 1.1% when using
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only 2 optimization runs. When using their optimal number of optimization runs with the
bagging method, binary classification beat ternary classification by about 1.4%. The false
positive rates for the ternary classification continue to outperform that of the binary
classification with the ternary improving by 4.5% when both using 2 runs and by 3%
when using the optimal number of runs. We can also see a that MCC is higher for the
ternary classification using bagging then binary by 1.4% when using 2 runs and by 0.3%
when using the optimal number of runs.
Table 6: RIPPER Performance Metrics for Bagging
TP
Rate

FP
Rate

Precision

Recall

F-Measure

IBD/N
O=2

96.7%

7.6%

96.7%

96.7%

96.7%

91.6% 99.3% 99.3%

IBD/N
O = 20

97.3%

5.8%

97.3%

97.3%

97.3%

93.2% 99.4% 99.2%

Ternary
O=2

95.6%

3.1%

95.7%

95.6%

95.65%

93.0% 99.2% 98.9%

Ternary
O = 10

95.9%

2.8%

96.0%

95.9%

93.9%

93.5% 99.3% 99.0%

MCC

ROC
Area

PRC
Area

This flip in accuracy does not continue for the boosting technique. The ternary
classification accuracy for boosting trailing the binary classification by 1.3% when using
only 2 optimization runs. When using their optimal number of optimization runs with the
boosting method, binary classification beat ternary classification by about 1.1%. The
false positive rates for the ternary classification continue to outperform that of the binary
classification with the ternary improving by 1.2% when both using 2 runs but when using
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the optimal number of runs, both binary and ternary classification have the same false
positive rate.
Table 7: RIPPER Performance Metrics for Boosting
TP
Rate

FP
Rate

IBD/N
O=2

98.5%

3.1%

98.5%

98.5%

98.5%

96.2% 99.8% 99.8%

IBD/N
O = 20

99.3%

1.1%

99.3%

99.3%

99.3%

98.3% 99.9% 99.9%

Ternary
O=2

97.2%

1.9%

97.2%

97.2%

97.2%

95.6% 99.6% 99.3%

Ternary
O = 10

98.2%

1.1%

98.2%

98.2%

98.2%

97.2% 99.7% 99.6%

Precision Recall

F-Measure

MCC

ROC
Area

PRC
Area

Despite the binary classification methods having better accuracy when performing
more optimization runs and when using ensemble learning methods, the ternary
classification is still the better option. The ternary classification also for a more specific
diagnosis and has consistently provide a lower false positive rate, except for using
boosting on the optimal number of runs. While using the binary classification using 20
optimization runs with boosting would provide the highest accuracy with a low false
positive rate, it loses the ease of readability that is provided by the single model and, as
previously said, IBD/nonIBD classification does not provide the specific diagnosis that
ternary classification provides.
8.4.2 CD/nonIBD vs UC/nonIBD
The CD/nonIBD problem has a small increase in accuracy that UC/nonIBD does
not see when the confidence factor decreases. The only change seen between confidence
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factor 0.25, 0.20, and 0.15 is an increase of 0.01% in the ROC Area and PRC Area with
0.20 and 0.15. Despite the slightly better accuracy seen in the CD/nonIBD problem
(0.1%) the UC/nonIBD consistently see a better false positive rate with a decrease of 1%
from the best CD/nonIBD tree and a better MCC with an increase of 0.9%. There is a
small fluctuation in the ROC Area when looking at the change between 0.25, 0.20, and
0.15 in the CD/nonIBD. There is a drop of 0.1% between 0.25 and 0.20 and gained that
0.1% back when using 0.15.
Table 8: C4.5 Performance Metrics using Different Confidence Factors
TP
Rate

FP
Rate

Precision Recall F-Measure

MCC

ROC
Area

PRC
Area

CD/N
91.1% 10.2%
C=0.25

91.1%

91.1%

91.1%

81.0%

93.1% 91.7%

CD/N
91.2% 10.0%
C=0.20

91.2%

91.2%

91.2%

81.2%

93.0% 91.6%

CD/N
91.2%
C=0.15

9.9%

91.2%

91.2%

91.2%

81.2%

93.1% 91.8%

UC/N
91.1%
C=0.25

8.9%

91.1%

91.1%

91.1%

82.1%

91.8% 89.4%

UC/N
91.1%
C=0.20

8.9%

91.1%

91.1%

91.1%

82.1%

91.9% 89.5%

UC/N
91.1%
C=0.15

8.9%

91.1%

91.1%

91.1%

82.1%

91.9% 89.5%

The bagging method does not show much potential for the CD/nonIBD and
UC/nonIBD with the smaller confidence factors. When investigating the bagging method,
the adjusted confidence factors for both CD/nonIBD and UC/nonIBD does not provide
promising results with none of the metrics improved. However, UC/nonIBD had a larger
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increase in accuracy between the single tree and the bagging method than the
CD/nonIBD despite its larger accuracy in the single trees. UC/nonIBD also continues to
have a lower false positive rate than CD/nonIBD.
Table 9: C4.5 Performance Metrics for Bagging
TP
Rate

FP
Rate

Precision

CD/N
C=0.25

94.4%

7.2%

CD/N
C=0.20

94.3%

CD/N
C=0.15

ROC
Area

PRC
Area

Recall F-Measure

MCC

94.4%

94.4%

94.4%

88.0% 98.7% 98.7%

7.4%

94.3%

94.3%

94.3%

87.8% 98.6% 98.7%

93.8%

8.0%

93.8%

93.8%

93.7%

86.7% 98.6% 98.6%

UC/N
C=0.25

95.8%

4.2%

95.8%

95.8%

95.8%

91.6% 98.9% 98.9%

UC/N
C=0.20

95.7%

4.3%

95.7%

95.7%

95.7%

91.4% 98.9% 98.8%

UC/N
C=0.15

95.4%

4.6%

95.4%

95.4%

95.4%

90.8% 98.8% 98.8%

The bagging method does not show much potential for the CD/nonIBD and
UC/nonIBD with the smaller confidence factors. Just like the bagging method, the
adjusted confidence factors for both CD/nonIBD and UC/nonIBD does not provide
promising results with none of the metrics improved. UC/nonIBD has better accuracy
and false positive rate then CD/nonIBD just like is seen in the bagging method discussed
before. There is a small fluctuation in the accuracy (TP Rate) when looking at the change
between 0.25, 0.20, and 0.15 in the CD/nonIBD. There is a drop of 0.6% between 0.25
and 0.20 and gained that 0.1% back when using 0.15.
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Table 10: C4.5 Performance Metrics for Boosting
TP
Rate

FP
Rate

Precision

Recall

F-Measure

MCC

ROC
Area

PRC
Area

CD/N
C=0.25

97.7%

3.1%

97.7%

97.7%

97.7%

95.1%

99.6%

99.7%

CD/N
C=0.20

96.9%

3.7%

96.9%

96.9%

96.9%

93.4%

99.4%

99.4%

CD/N
C=0.15

96.7%

4.3%

96.7%

96.7%

96.7%

92.9%

99.5%

99.6%

UC/N
C=0.25

98.0%

2.0%

98.0%

98.0%

98.0%

95.9%

99.8%

99.8%

UC/N
C=0.20

97.4%

2.6%

97.4%

97.4%

97.4%

94.9%

99.8%

99.8%

UC/N
C=0.15

98.0%

2.0%

98.0%

98.0%

98.0%

95.9%

99.8%

99.8%

Looking CD/nonIBD and UC/nonIBD using this dataset does not seem to be an
avenue for future study for this particular dataset. While they do provide accuracies that
are improvements to other studies, they do not complete with the ternary classification.
The ternary classification provides a diagnosis that is more specific because it can
determine if a patient has CD, UC, or nonIBD with a model that has higher accuracy and
a lower false positive rate.

8.5 Colonoscopy
The study produces many models that beat the accuracy of a colonoscopy. If one
of these models or similar models could be incorporated or formed into medical
diagnostic test, a stool test could be more accurate than an endoscopy like a colonoscopy.

52

Out of the current tests ordered to diagnosis, patients are most comfortable with a stool
test. Patients have less anxiety about the pain, cost, outcome, and time of a stool test then
a colonoscopy [9]. This would allow patients to only need to undergo a colonoscopy if it
is truly necessary. If a diagnosis does come back as IBD positive, the patient would
eventually need to have a colonoscopy perform, however this would allow for anyone
without IBD to forgo the stress and expensive of a colonoscopy. The current stool test is
also one of the test that patients are most comfortable with and is the least like to be
refused by the patient when suggested by a medical professional [9]. This would allow
medical professionals to have a test with higher accuracy that would be less likely refused
by the patient and not increase the nerves of a patient without cause until more
information can be collected.

8.6 Future Work
Future work will focus on attribute selection and importance. This would include
making a data subset with only concentrations of bacteria genus and subset with only
bacteria species concentrations, instead of looking at the concentrations of all the
following: kingdom, phylum, class, order, family, genus, species, and trinomen
(subspecies). This would determine if a bacteria genus has more or less of an impact on
diagnosis then knowing the specific bacteria species. The only model that outperformed
this study was using attribute selection by boosting (r = 1%) during the Geurts’ study [13]
so attribute selection has potential to improve the accuracy.
The investigation what attributes from the metadata are important to the diagnosis
of the IBD. Also, the use of WEKA’s attribute evaluator, such as CfsSubsetEval and
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InfoGainAttributeEval, to help determine the importance of different data subsets and/or
the importance of specific attributes to the problem.
Addition future work would also investigate the varies other datasets that are
available on the IBDMDB. These datasets include 16S, Serology, Proteomics, Viromics,
Metabolites, Metatranscriptomes, and Host Transriptomes datasets collected by the
HMP2. This would allow for an investigation to what types of data is more useful for the
diagnosis problem at hand.
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Chapter 9. Conclusion
The RIPPER algorithm is the best choice for both IBD/nonIBD and Ternary
classification. While there is a decision tree with a larger accuracy when looking at
IBD/nonIBD classification, the size of the tree is significantly larger than the RIPPER
algorithm which has accuracy that is roughly the same. The C4.5 decision tree provides a
better model for CD/nonIBD and UC/nonIBD, however their accuracy cannot compete
with the IBD/nonIBD and Ternary classification. The RIPPER algorithm using the
Ternary classification with the all subset is the best models given this problem given its
accuracy, readability, and its ability to provide a more specific diagnosis.
The decrease of bacteria genus Alistipes, genus Coprococcus and other bacteria
species have been shown to increase the chance of IBD in patients. These bacteria are
present and important in the C4.5 decision trees and the rules created by the RIPPER
algorithm across multiple classification problems. While race/ethnicity is known to have
an effect on a patient likelihood of having IBD, it appears to have a larger impact on the
CD/nonIBD and Ternary classification with a more significant impact on Ternary
classification.
The models presented in this study have promise in the diagnosis of IBD because
their accuracy surpass that of the colonoscopy. It would also have the potential to provide
a test that is less costly and less stressful for patients and less likely to be refused when
ordered by a medical professional.
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